Developing new treatments to combat bacterial resistance using biopharmaceuticals
Preclinical Services for Antibacterial Resistance Biopharmaceutical Product Development
This study is working on new treatments to help fight infections caused by bacteria that don't respond to regular antibiotics, and it's designed for patients who need better options for their infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dynport Vaccine Company, LLC NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-10934722 on NIH RePORTER |
What this research studies
This research focuses on the preclinical development of innovative biopharmaceutical products aimed at addressing bacterial drug resistance. It utilizes advanced biotechnology processes to create materials such as monoclonal antibodies, recombinant proteins, and small interfering RNA (siRNA) vectors. The program includes comprehensive services like product development planning, assay development, and regulatory support to ensure effective translation of these products into clinical settings. Patients may benefit from new therapies that could effectively treat infections caused by resistant bacteria.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant bacteria.
Not a fit: Patients with infections that are not caused by bacterial resistance may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new therapies that effectively combat bacterial infections resistant to current treatments.
How similar studies have performed: Other research in the field of biopharmaceuticals and antibacterial resistance has shown promising results, indicating that this approach has potential for success.
Where this research is happening
Frederick, United States
- Dynport Vaccine Company, LLC — Frederick, United States (Active)
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.